Skip to main content
Equibles

Legal & General Group Plc

Position in TNXP — Tonix Pharmaceuticals Holding Corp.

CIK 764068 London, X0
Back to TNXP Full portfolio

Position in TNXP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$18,757
+$4,279 QoQ
Shares Held
1,470
+39.6% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 103 holders
Holding Since
Jun 2021
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TNXP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. TNXP ranks #246 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in TNXP

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,757 1,470
2026-03-31 $14,478 1,053
2025-12-31 $16,447 1,053
2025-09-30 $20,125 833
2025-06-30 $24,790 689
2022-06-30 $1,847 1,169
2022-03-31 $8,598 37,384
2021-12-31 $13,458 37,384
2021-09-30 $18,093 30,155
2021-06-30 $28,955 26,086